Biotech · Public company · Carlsbad, CA, US
Design Therapeutics, Inc.
Ticker DSGN · SEC CIK 0001807120
Track this companyFree. Adds Design Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- DT-168Phase 2 · Fuchs Endothelial Corneal DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- DT-216Phase 1 · Friedreich AtaxiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyPHASE2 · RECRUITING · started Jul 30, 2025ClinicalTrials.gov NCT07024693 · fetched Nov 12, 2026
- Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich AtaxiaPHASE1 · COMPLETED · started Sep 27, 2022ClinicalTrials.gov NCT05573698 · fetched Nov 12, 2026
- Study to Evaluate DT-216 in Adult Patients With Friedreich AtaxiaPHASE1 · COMPLETED · started Mar 11, 2022ClinicalTrials.gov NCT05285540 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 18, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 1, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 30, 2026 · fetched Nov 12, 2026